Rheumatology, Allergy & Immunology Newsletter

In a Q&A, Eugenia Chock, MD, PhD, assistant professor of medicine (rheumatology, allergy and immunology at Yale School of Medicine, discusses why early diagnosis of autoimmune conditions in women is important, how machine learning can help, and her hopes for the future of artificial intelligence in medicine.

Hyaluronic acid lip fillers are safe and effective for patients with systemic sclerosis, or scleroderma, a new Yale study finds. The study was directed by Kathleen Suozzi, MD, associate professor of dermatology, and Monique Hinchcliff, MD, MS, associate professor of medicine (rheumatology, allergy & immunology) and director of the Yale Scleroderma Program.

In a new study, Yale researchers identified a molecule that binds to a disease-associated macrophage migration inhibitory factor (MIF) gene variant. The discovery, they say, could lead to the development of a new generation of precision medicine-based therapies that address diverse autoimmune and inflammatory conditions.

Six Yale Department of Internal Medicine faculty members—many of whom are athletes in their own right—discuss evidence-based ways to enhance sports performance.

Meet Marat Kribis, MD, a clinical fellow in the Section of Rheumatology, Allergy and Immunology, who enjoys learning from mentors who have made discoveries in their fields.

Meet Luke Legakis, MD, PhD, a clinical fellow in the Section of Rheumatology, Allergy and Immunology at Yale School of Medicine, who enjoys learning about his patients’ perspectives and backgrounds within the context of their illnesses.